发明名称 SETT ATT FRAMSTELLA EN IMMUNGLOBULINLOSNING
摘要 Prodn. of immunoglobulin (IG) soln. for intravenous application comprises slurrying a salt-contg. (IG) soln. with aq. wet, amorphous, chamically-pure silicic acid (I) of submicroscopic size distribution so as to purify the suspension by adsorption. Mixt. is adjusted to pH 6.8 (at 20 degrees C), incubated with stirring for 30-60 min at about 20 degrees C, then (I) removed and the whole procedure repeated at pH 6.5(at 20 degrees C). Pref. as many purificn. stages are carried out as needed to reduce the content of substances with anticomplement activity to the desired level, and the amt. of (I) used is given by the equations CP:Cs = 1:Z = Cp (g/dl): m damp SiO2(g)X100/Vp(ml). damp SiO2(g) = Z.Cp.Vp/100. (C,m,V are not defined; subscripts p and s refer to protein and suspension). Solns. are used in passive immunoprophylaxis of lagammaglobulinaemia and other antibody deficiency conditions, and of infections diseases. These highly purified solns. have few or no side effects, good antibacterial, antiviral and antitoxin activities, and acceptable residence time in the organism.
申请公布号 SE7906272(L) 申请公布日期 1980.02.26
申请号 SE19790006272 申请日期 1979.07.23
申请人 BLUTSPENDEDIENST DES LANDESVER 发明人 BUNNIG K
分类号 A61K39/395;A61K38/00;C07K16/06;(IPC1-7):61K37/04;61K37/06 主分类号 A61K39/395
代理机构 代理人
主权项
地址